Clinical Trial Details
| Trial ID: | L2797 |
| Source ID: | NCT00036504 |
| Associated Drug: | Insulin Lispro Low Mixture |
| Title: | Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: Insulin Lispro low mixture |
| Outcome Measures: | |
| Sponsor/Collaborators: | Sponsor: Eli Lilly and Company |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 100 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2001-08 |
| Completion Date: | 2002-08 |
| Results First Posted: | |
| Last Update Posted: | 2010-10-13 |
| Locations: | LaJolla, California, United States|Walnut Creek, California, United States|New Britain, Connecticut, United States|Longwood, Florida, United States|Atlanta, Georgia, United States|Fayetteville, Georgia, United States|Boise, Idaho, United States|Springfield, Illinois, United States|Mt. Laurel, New Jersey, United States|New Brunswick, New Jersey, United States|Syracuse, New York, United States|Chattanooga, Tennessee, United States|Dallas, Texas, United States |
| URL: | https://clinicaltrials.gov/show/NCT00036504 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|